3 Item 1A. Risk Factors 49 Item 1B. Unresolved Staff Comments 104 Item 1C. Cybersecurity 104 Item 2. Properties 104 Item 3. Legal Proceedings 105 Item 4. Mine Safety Disclosures 105 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 106 Item 6. [Reserved] 106 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 107 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 12...
Q2 FY2026 — expected 2026-09-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-31 | 2025-12-31 | 0001193125-26-133372 | EDGAR | 104K words |
| 2025-03-31 | 2024-12-31 | 0000950170-25-047212 | EDGAR | — |
| 2024-03-29 | 2023-12-31 | 0001437749-24-010123 | EDGAR | — |
| 2023-03-31 | 2022-12-31 | 0001437749-23-008834 | EDGAR | — |
| 2022-03-02 | 2021-12-31 | 0001583648-22-000016 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001583648-21-000005 | EDGAR | — |
| 2020-03-13 | 2019-12-31 | 0001583648-20-000015 | EDGAR | — |
| 2019-03-18 | 2018-12-31 | 0001583648-19-000011 | EDGAR | — |
| 2018-03-15 | 2017-12-31 | 0001583648-18-000017 | EDGAR | — |
| 2017-03-30 | 2016-12-31 | 0001193125-17-102052 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001193125-25-276119 | EDGAR | 24K words |
| 2025-08-14 | 2025-06-30 | 0000950170-25-108438 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0000950170-25-071998 | EDGAR | — |
| 2024-11-13 | 2024-09-30 | 0001437749-24-034891 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0001437749-24-026778 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0001437749-24-017037 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001437749-23-031957 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0001437749-23-023085 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001437749-23-013687 | EDGAR | — |
| 2022-11-04 | 2022-09-30 | 0001437749-22-026023 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0001583648-22-000065 | EDGAR | — |
| 2022-05-11 | 2022-03-31 | 0001583648-22-000025 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-31 | 0001193125-26-133332 | EDGAR | 3K words |
| 2026-02-26 | 0001104659-26-020667 | EDGAR | — |
| 2026-02-24 | 0001104659-26-019143 | EDGAR | — |
| 2026-02-24 | 0001193125-26-065308 | EDGAR | — |
| 2026-02-24 | 0001193125-26-065159 | EDGAR | — |
| 2026-01-29 | 0001193125-26-029341 | EDGAR | — |
| 2026-01-12 | 0001193125-26-009724 | EDGAR | — |
| 2025-12-15 | 0001104659-25-120789 | EDGAR | — |
| 2025-11-10 | 0001193125-25-274378 | EDGAR | — |
| 2025-11-05 | 0001104659-25-106591 | EDGAR | — |
305 total filings indexed. 273 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001583648 |
| Ticker | PVLA |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | NV |
| Website | https://www.palvellatx.com |
| Listed | 2024-12-16 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report